These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5314809)

  • 1. Clinical investigation of intermediate- and high-purity antihaemophilic factor (factor VIII) concentrates.
    Johnson AJ; Karpatkin MH; Newman J
    Br J Haematol; 1971 Jul; 21(1):21-41. PubMed ID: 5314809
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.
    Mannucci PM; Ruggeri ZM; Pareti FI; Capitanio A
    Lancet; 1977 Apr; 1(8017):869-72. PubMed ID: 67283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and neoplastic diseases. Haemophilia and related disorders.
    Rizza CR
    Br Med J; 1974 Oct; 4(5935):36-8. PubMed ID: 4547674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cryoprecipitates rich in factor VIII. In vitro and in vivo studies].
    Parquet-Gernez A; Bauters F
    Rev Fr Transfus; 1969 Dec; 12(4):439-50. PubMed ID: 5310871
    [No Abstract]   [Full Text] [Related]  

  • 5. THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).
    ABILDGAARD CF; CORNET JA; FORT E; SCHULMAN I
    Br J Haematol; 1964 Apr; 10():225-37. PubMed ID: 14141621
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical care of patients with hereditary disorders of blood coagulation.
    Shulman NR
    Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
    Brinkhous KM; Hedner U; Garris JB; Diness V; Read MS
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1382-6. PubMed ID: 2784006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery in children with congenital disorders of blood coagulation.
    Dudley NE; Kernoff PB; Gough MH
    J Pediatr Surg; 1971 Dec; 6(6):689-701. PubMed ID: 5316141
    [No Abstract]   [Full Text] [Related]  

  • 11. Cryoprecipitate and the use of the plastic blood bag system in the management of haemophilia and other coagulation disorders.
    Dormandy KM
    Proc R Soc Med; 1968 Jun; 61(6):595-8. PubMed ID: 5301887
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand factor and platelet adhesiveness.
    Meyer D; Larrieu MJ
    J Clin Pathol; 1970 Apr; 23(3):228-31. PubMed ID: 5310275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 14. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 15. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of inherited coagulation disorders].
    Blombäck M; Nilsson IM
    Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
    [No Abstract]   [Full Text] [Related]  

  • 17. Canine von Willebrand's disease.
    Dodds WJ
    J Lab Clin Med; 1970 Nov; 76(5):713-21. PubMed ID: 5312238
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.